INmune Bio, Inc. (INMB) Ownership

$2.08

south_east
-$0.06 (-2.8%)
Day's range
$2.08
Day's range
$2.15

INmune Bio, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 11/12/2025 1.19 M $2.46 M   1.23% 5.09%
VANGUARD GROUP INC 11/07/2025 876.29 K $1.81 M   3.37% 3.76%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 469.44 K $972.01 K   20.39% 2.01%
STATE STREET CORP 11/14/2025 283.83 K $587.53 K   3.07% 1.22%
RAYMOND JAMES FINANCIAL INC 11/14/2025 268.46 K $555.71 K   -19.50% 1.15%
CITADEL ADVISORS LLC 11/14/2025 200.60 K $415.24 K   -55.20% 0.86%
NORTHERN TRUST CORP 11/14/2025 189.12 K $391.47 K   15.02% 0.81%
CITADEL ADVISORS LLC 11/14/2025 176.10 K $364.53 K   -56.51% 0.76%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 156.95 K $324.90 K   686.93% 0.67%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 155.60 K $322.09 K   -50.78% 0.67%
UBS GROUP AG 11/13/2025 155.52 K $321.93 K   -65.38% 0.67%
WESTSIDE INVESTMENT MANAGEMENT, INC. 11/04/2025 103.45 K $214.15 K   383.98% 0.44%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 96.20 K $199.13 K   -87.55% 0.41%
MORGAN STANLEY 11/14/2025 75.71 K $156.72 K   -26.31% 0.33%
DEUTSCHE BANK AG\ 11/13/2025 61.71 K $127.74 K   20,748.65% 0.26%
BANK OF NEW YORK MELLON CORP 11/03/2025 59.85 K $123.89 K   -2.85% 0.26%
JPMORGAN CHASE & CO 11/26/2025 57.71 K $119.47 K   -21.04% 0.25%
JANE STREET GROUP, LLC 11/14/2025 49.57 K $102.62 K   100.00% 0.21%
XTX TOPCO LTD 11/14/2025 48.74 K $100.90 K   -61.27% 0.21%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 41.83 K $86.58 K   -19.30% 0.18%
BUCKINGHAM STRATEGIC PARTNERS 11/12/2025 40.95 K $84.77 K   -16.11% 0.18%
GROUP ONE TRADING, L.P. 11/12/2025 38.58 K $79.87 K   100.00% 0.17%
PNC FINANCIAL SERVICES GROUP, INC. 11/07/2025 38.39 K $79.46 K   1.78% 0.16%
WOLVERINE TRADING, LLC 11/14/2025 33.30 K $70.26 K   100.00% 0.14%
BARCLAYS PLC 11/12/2025 30.01 K $62.11 K   -21.01% 0.13%
WOLVERINE TRADING, LLC 11/14/2025 29.19 K $61.60 K   100.00% 0.13%
LAIRD NORTON TRUST COMPANY, LLC 11/14/2025 25.00 K $51.75 K   -32.43% 0.11%
RHUMBLINE ADVISERS 11/06/2025 22.65 K $46.88 K   1.40% 0.10%
ALLIANCEBERNSTEIN L.P. 11/14/2025 21.95 K $45.44 K   0.00% 0.09%
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. 11/12/2025 21.38 K $44.00 K   -34.38% 0.09%
AQR CAPITAL MANAGEMENT LLC 11/14/2025 20.31 K $42.03 K   100.00% 0.09%
LMR PARTNERS LLP 11/14/2025 16.60 K $34.36 K   100.00% 0.07%
NUVEEN, LLC 11/12/2025 16.52 K $34.19 K   0.00% 0.07%
MODERA WEALTH MANAGEMENT, LLC 10/31/2025 15.46 K $31.99 K   0.00% 0.07%
GOLDMAN SACHS GROUP INC 11/14/2025 15.30 K $31.68 K   -35.15% 0.07%
SQUAREPOINT OPS LLC 11/14/2025 14.56 K $30.14 K   100.00% 0.06%
INDEPENDENT ADVISOR ALLIANCE 11/04/2025 14.50 K $30.02 K   100.00% 0.06%
CARY STREET PARTNERS FINANCIAL LLC 11/10/2025 13.92 K $28.81 K   100.00% 0.06%
WELLS FARGO & COMPANY/MN 11/13/2025 13.89 K $28.75 K   43.42% 0.06%
WOLVERINE TRADING, LLC 11/14/2025 13.20 K $27.85 K   100.00% 0.06%
SIMPLEX TRADING, LLC 11/12/2025 12.51 K $25.00 K   -82.22% 0.05%
MARINER, LLC 11/14/2025 12.33 K $25.53 K   13.35% 0.05%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2025 11.73 K $24.28 K   100.00% 0.05%
SG AMERICAS SECURITIES, LLC 10/23/2025 10.78 K $22.00 K   100.00% 0.05%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 10.58 K $21.90 K   -57.91% 0.05%
BEACON POINTE ADVISORS, LLC 11/14/2025 10.37 K $21.46 K   0.00% 0.04%
BANK OF AMERICA CORP /DE/ 11/14/2025 10.19 K $21.09 K   -16.31% 0.04%
DAVENPORT & CO LLC 10/15/2025 10.00 K $20.70 K   0.00% 0.04%
MAI CAPITAL MANAGEMENT 11/10/2025 7.79 K $16.13 K   -83.84% 0.03%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 11/14/2025 7.51 K $15.55 K   -17.59% 0.03%

INmune Bio, Inc. institutional Ownership - FAQ's

During the previous two years, 105 institutional investors and hedge funds held shares of INmune Bio, Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 1.19 M

VANGUARD GROUP INC: 876,292

GEODE CAPITAL MANAGEMENT, LLC: 469,440

STATE STREET CORP: 283,833

RAYMOND JAMES FINANCIAL INC: 268,460

NORTHERN TRUST CORP: 189,116

19.97% of INmune Bio, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 6.61 M shares in the last 24 months. This purchase volume represents approximately $13.75 M in transactions.